Search results for: Precision Medicine
Filter search results
Previews of Forthcoming Publications
27 July 2011
…of the problem of insufficient affordable medicines in developing countries and detail policies and proposals intended to increase access to global medicines. With respect to neglected diseases, the paper examines policies…
New: Operationalising Value Based Pricing
11 August 2011
…by NICE. The Department of Health has stated that it will include “the range of factors through which medicines deliver benefits for patients and society”. To date, the UK Government…
Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?
1 February 2024
…is seen most clearly when costs and benefits occur at different points in time. In a healthcare context, this is most apparent when evaluating advanced therapy medicinal products (ATMPs), medicines…
Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing
13 October 2011
…R&D in global health. Value-based pricing (VBP), due to be implemented in the UK for newly marketed medicines as from 2014, remains a key focus of OHE activities. At a…
Is It Time to Reconsider the Role of Co-Payments in Europe?
11 January 2012
…many countries, primarily for medicines, and designed to achieve one of two objectives. The first has been to reduce moral hazard by requiring patients to pay an ‘entry fee’ to…
OHE Conference on Drug Development in 2022: Update
18 July 2012
…of Medicine, Oxford University Dr Rob Epstein, former President, United BioSource Corporation, and President, Advanced Clinical Science & Research and Chief Clinical Research & Development Officer, Medco Health Solutions Mr….
New OHE Study Compares Decisions by Five HTA Agencies on Oncology Meds
31 January 2013
Just out in the International Journal of Technology Assessment in Health Care is an important new study that reviews appraisals of breast cancer and colorectal cancer medicines by HTA agencies…
Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics
16 January 2024
…company maintaining a ‘security stock’ of each product available for use in Sweden (Folkhälsomyndigheten, 2023). The model was partially delinked, with regions continuing to pay for medicines used as they…
Pharmaceuticals in seven nations
1 May 1985
…the reader’s attention is drawn to Pharmaceuticals among problems of supplying medicines to the Third World have been extensively discussed elsewhere (see, for example, Medicines, Health and the Poor World…